Ryoichi Shimizu

A phase ΙI study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study)

Shoichi Hazama, Yusuke Nakamura, Hiroaki Tanaka et al. · Journal of Translational Medicine · 2014 · 87 citations · Full text

Medicine, Immunology, Pharmacology +17

Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: <scp>VENUS</scp> ‐ <scp>PC</scp> study

Nobuaki Suzuki, Shoichi Hazama, Haruo Iguchi et al. · Cancer Science · 2016 · 65 citations · Full text

Pharmacy, Immunology, Oncology +16

Randomised phase III study of S-1 alone versus S-1 plus lentinan for unresectable or recurrent gastric cancer (JFMC36-0701)

Shigefumi Yoshino, Kazuhiro Nishikawa, Satoshi Morita et al. · European Journal of Cancer · 2016 · 48 citations · Full text

Medicine, Immunology, Oncology +17

miR‐125b‐1 and miR‐378a are predictive biomarkers for the efficacy of vaccine treatment against colorectal cancer

Hironori Tanaka, Shoichi Hazama, Michihisa Iida et al. · Cancer Science · 2017 · 48 citations · Full text

Medicine, Cancer Biology, Oncology +17

Phase I study of irinotecan and doxifluridine for metastatic colorectal cancer focusing on the <i>UGT1A1*28</i> polymorphism

Shoichi Hazama, Atsushi Nagashima, Hiroshi Kondo et al. · Cancer Science · 2009 · 35 citations · Full text

Medicine, Oncology, Pharmacology +16